[1] Qin FL, Sang GY, Zou XQ, et al. Drug-induced liver injury during consolidation therapy in childhood acute lymphoblastic leukemia as assessed for causality using the updated RUCAM. Can J Gastroenterol Hepatol, 2022, 2022: 5914593. [2] Mihajlovic M, Vinken M. Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods. Int J Mol Sci, 2022, 23(6): 3315. [3] Abdulkhaleq FM, Alhussainy TM, Badr MM, et al. Antioxidative stress effects of vitamins C, E, and B12, and their combination can protect the liver against acetaminophen-induced hepatotoxicity in rats. Drug Des Devel Ther, 2018,12: 3525-3533. [4] Yin Y, Zhang Y, Li H,et al. Triterpenoids from fruits of Sorbus pohuashanensis inhibit acetaminophen-induced acute liver injury in mice. Biomed Pharmacother, 2018,109:493-502. [5] Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology, 2019, 156(8):2230-2241,e11. [6] Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers, 2019, 5(1): 58. [7] Chen M,Suzuki A, Borlak J, et al. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol, 2015, 63: 503-514. [8] Kim SH, Naisbitt DJ. Update on advances in research on idiosyncratic drug-induced liver injury. Allergy Asthma Immunol Res, 2016, 8: 3-11. [9] 王瑜, 仇丽霞, 范作鹏, 等. 不同类型的急性药物性肝损伤患者临床特征比较. 临床肝胆病杂志, 2021, 37(3): 632-635. [10] Kaplowitz N. Drug-induced liver injury. Clin Infect Dis, 2004, 38(Suppl 2): S44-48. [11] Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30: 277-294. [12] Xu P, Zhou H, Li YZ, et al. Baicalein enhances the oral bioavailability and hepatoprotective effects of silybin through the inhibition of efflux transporters BCRP and MRP2. Front Pharmacol, 2018,9:1115. [13] Shahnazarian V, Ramai D, Reddy M. A rare case of ibuprofen-induced acute liver injury. Cureus, 2018,10(8):e3225. [14] Allard J, Le Guillou D, Begriche K, et al. Drug-induced liver injury inobesity and nonalcoholic fatty liver disease. Adv Pharmacol, 2019, 85: 75-107. [15] Pais R, Rusu E, Ratziu V. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. Clin Liver Dis, 2014, 18(1): 165-178. [16] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 中华肝脏病杂志, 2015, 23(11): 810-820. [17] 刘如玉, 路遥, 申戈, 等. HBeAg阴性初治慢乙肝患者恩替卡韦4年抗病毒治疗FIB-4评分动态变化研究. 中华实验和临床病毒学杂志, 2020,34(1): 51-56. [18] Labbe G, Pessayre D, Fromenty B. Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol, 2008, 22: 335-353. [19] Huang YS, Tseng SY, Chen WW, et al. Clinical characteristics and outcomes of drug-induced liver injury in Taiwan: With emphasis on the impact of chronic hepatitis B infection. J Chin Med Assoc, 2022, 85(3): 286-294. [20] Devarbhavi H, Joseph T, Sunil Kumar N, et al. The Indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markersin 1288 patients. J Clin Exp Hepatol, 2021, 11(3): 288-298. [21] Yu Q, Ma X, Wang Y, et al. Dietary cholesterol exacerbates statin-induced hepatic toxicity in syrian golden hamsters and in patients in an observational cohort study. Cardiovasc Drugs Ther, 2021,35(2): 367-380. [22] Bril F, Portillo Sanchez P, Lomonaco R, et al. Liver safety of statins in prediabetes or T2DM and nonalcoholic steatohepatitis: Post hoc analysis of a randomized trial. J Clin Endocrinol Metab, 2017, 102: 2950-2961. [23] de Abajo FJ, Montero D,Madurga M, et al. Acute and clinically relevant drug-induced liver injury: A population based case-control study. Br J Clin Pharmacol, 2004, 58: 71-80. [24] Bagheri H, Michel F, Lapeyre-Mestre M, et al. Detection and incidence of drug-induced liver injuries inhospital: A prospective analysis from laboratory signals. Br J Clin Pharmacol, 2000, 50: 479-484. [25] Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 2008, 135: 1924-1934. [26] Zhou Y, Yang L, Liao Z, et al. Epidemiology of drug-induced liver injury in China: A systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol, 2013, 25: 825-829. |